EW logo

Edwards Lifesciences (EW) Total Liabilities

Annual Total Liabilities

$2.64 B
+$158.00 M+6.36%

December 31, 2023


Summary


Performance

EW Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEWbalance sheetmetrics:

Quarterly Total Liabilities

$3.36 B
+$765.10 M+29.49%

September 30, 2024


Summary


Performance

EW Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEWbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

EW Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+6.4%+27.1%
3 y3 years-0.7%+28.3%
5 y5 years+21.1%+56.2%

EW Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-0.9%+6.4%at high+38.8%
5 y5-year-0.9%+13.0%at high+54.5%
alltimeall time-2.5%+1141.2%at high+708.4%

Edwards Lifesciences Total Liabilities History

DateAnnualQuarterly
Sep 2024
-
$3.36 B(+29.5%)
Jun 2024
-
$2.59 B(+1.8%)
Mar 2024
-
$2.55 B(-3.6%)
Dec 2023
$2.64 B(+6.4%)
$2.64 B(+0.0%)
Sep 2023
-
$2.64 B(+3.4%)
Jun 2023
-
$2.56 B(-1.2%)
Mar 2023
-
$2.59 B(+4.2%)
Dec 2022
$2.49 B(-6.8%)
$2.49 B(+2.7%)
Sep 2022
-
$2.42 B(-2.5%)
Jun 2022
-
$2.48 B(-3.6%)
Mar 2022
-
$2.58 B(-3.4%)
Dec 2021
$2.67 B(+0.1%)
$2.67 B(+1.8%)
Sep 2021
-
$2.62 B(+3.6%)
Jun 2021
-
$2.53 B(-1.0%)
Mar 2021
-
$2.56 B(-4.0%)
Dec 2020
$2.66 B(+13.8%)
$2.66 B(+2.8%)
Sep 2020
-
$2.59 B(+0.2%)
Jun 2020
-
$2.58 B(+18.9%)
Mar 2020
-
$2.17 B(-7.0%)
Dec 2019
$2.34 B(+7.2%)
$2.34 B(+8.8%)
Sep 2019
-
$2.15 B(+3.8%)
Jun 2019
-
$2.07 B(+2.5%)
Mar 2019
-
$2.02 B(-7.4%)
Dec 2018
$2.18 B(-19.4%)
$2.18 B(-15.9%)
Sep 2018
-
$2.60 B(+3.0%)
Jun 2018
-
$2.52 B(-2.2%)
Mar 2018
-
$2.58 B(-4.8%)
Dec 2017
$2.71 B(+43.3%)
$2.71 B(+16.5%)
Sep 2017
-
$2.33 B(+5.8%)
Jun 2017
-
$2.20 B(+7.9%)
Mar 2017
-
$2.04 B(+7.8%)
Dec 2016
$1.89 B(+21.7%)
$1.89 B(+14.8%)
Sep 2016
-
$1.65 B(+4.2%)
Jun 2016
-
$1.58 B(+1.7%)
Mar 2016
-
$1.55 B(+0.1%)
Dec 2015
$1.55 B(+16.6%)
$1.55 B(+6.7%)
Sep 2015
-
$1.46 B(+10.3%)
Jun 2015
-
$1.32 B(+3.5%)
Mar 2015
-
$1.27 B(-4.3%)
Dec 2014
$1.33 B(+14.3%)
$1.33 B(+1.9%)
Sep 2014
-
$1.31 B(-7.4%)
Jun 2014
-
$1.41 B(+7.7%)
Mar 2014
-
$1.31 B(+12.5%)
Dec 2013
$1.17 B(+57.0%)
$1.17 B(+6.6%)
Sep 2013
-
$1.09 B(+43.9%)
Jun 2013
-
$759.90 M(+7.8%)
Mar 2013
-
$704.60 M(-5.1%)
Dec 2012
$742.20 M
$742.20 M(+12.5%)
Sep 2012
-
$659.50 M(+3.0%)
Jun 2012
-
$640.50 M(+4.3%)
DateAnnualQuarterly
Mar 2012
-
$613.90 M(-4.5%)
Dec 2011
$642.60 M(+40.0%)
$642.60 M(+2.3%)
Sep 2011
-
$628.30 M(+1.8%)
Jun 2011
-
$617.20 M(+7.7%)
Mar 2011
-
$573.30 M(+24.9%)
Dec 2010
$459.00 M(+0.3%)
$459.00 M(-6.7%)
Sep 2010
-
$491.90 M(-6.1%)
Jun 2010
-
$524.10 M(+15.7%)
Mar 2010
-
$452.90 M(-1.0%)
Dec 2009
$457.60 M(-12.2%)
$457.60 M(-10.6%)
Sep 2009
-
$511.70 M(+10.8%)
Jun 2009
-
$462.00 M(+11.2%)
Mar 2009
-
$415.60 M(-20.3%)
Dec 2008
$521.40 M(+2.2%)
$521.40 M(+2.9%)
Sep 2008
-
$506.70 M(+12.4%)
Jun 2008
-
$451.00 M(-15.3%)
Mar 2008
-
$532.70 M(+4.4%)
Dec 2007
$510.10 M(+2.6%)
$510.10 M(+7.2%)
Sep 2007
-
$475.90 M(+7.1%)
Jun 2007
-
$444.30 M(-4.3%)
Mar 2007
-
$464.20 M(-6.7%)
Dec 2006
$497.40 M(-7.7%)
$497.40 M(-2.9%)
Sep 2006
-
$512.40 M(-4.5%)
Jun 2006
-
$536.80 M(+4.0%)
Mar 2006
-
$516.00 M(-4.3%)
Dec 2005
$539.10 M(+11.2%)
$539.10 M(+11.0%)
Sep 2005
-
$485.80 M(-0.7%)
Jun 2005
-
$489.10 M(+3.0%)
Mar 2005
-
$475.00 M(-2.0%)
Dec 2004
$484.60 M(+3.9%)
$484.60 M(+2.5%)
Sep 2004
-
$472.60 M(-6.1%)
Jun 2004
-
$503.40 M(-5.7%)
Mar 2004
-
$533.60 M(+14.4%)
Dec 2003
$466.30 M(+0.3%)
$466.30 M(-5.2%)
Sep 2003
-
$492.10 M(-5.5%)
Jun 2003
-
$520.70 M(+5.6%)
Mar 2003
-
$492.90 M(+6.0%)
Dec 2002
$465.00 M(-11.3%)
$465.00 M(+1.2%)
Sep 2002
-
$459.60 M(-8.8%)
Jun 2002
-
$503.70 M(+5.1%)
Mar 2002
-
$479.10 M(-8.6%)
Dec 2001
$524.20 M(-21.4%)
$524.20 M(-4.2%)
Sep 2001
-
$547.00 M(-7.5%)
Jun 2001
-
$591.50 M(-7.4%)
Mar 2001
-
$638.90 M(-4.2%)
Dec 2000
$667.00 M(+213.1%)
$667.00 M(-2.1%)
Sep 2000
-
$681.40 M(-4.3%)
Jun 2000
-
$712.00 M(+2.0%)
Mar 2000
-
$698.00 M
Dec 1999
$213.00 M
-

FAQ

  • What is Edwards Lifesciences annual total liabilities?
  • What is the all time high annual total liabilities for Edwards Lifesciences?
  • What is Edwards Lifesciences annual total liabilities year-on-year change?
  • What is Edwards Lifesciences quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Edwards Lifesciences?
  • What is Edwards Lifesciences quarterly total liabilities year-on-year change?

What is Edwards Lifesciences annual total liabilities?

The current annual total liabilities of EW is $2.64 B

What is the all time high annual total liabilities for Edwards Lifesciences?

Edwards Lifesciences all-time high annual total liabilities is $2.71 B

What is Edwards Lifesciences annual total liabilities year-on-year change?

Over the past year, EW annual total liabilities has changed by +$158.00 M (+6.36%)

What is Edwards Lifesciences quarterly total liabilities?

The current quarterly total liabilities of EW is $3.36 B

What is the all time high quarterly total liabilities for Edwards Lifesciences?

Edwards Lifesciences all-time high quarterly total liabilities is $3.36 B

What is Edwards Lifesciences quarterly total liabilities year-on-year change?

Over the past year, EW quarterly total liabilities has changed by +$716.10 M (+27.09%)